E
Cogent Biosciences, Inc. COGT
$12.23 $0.443.73% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -24.73% -23.37% -24.95% -27.54% -33.75%
Total Depreciation and Amortization 7.13% 6.75% 39.55% 28.30% -11.18%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -20.63% 13.20% 61.80% -56.98% 95.97%
Change in Net Operating Assets 204.15% -45.38% -122.88% 94.41% -41.03%
Cash from Operations -27.73% -26.62% -37.46% -36.90% -33.17%
Capital Expenditure 11.49% -681.43% 76.19% -131.40% 88.23%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 110.70% 6,177.02% 471.51% 166.88% -10.57%
Cash from Investing 110.53% 6,545.50% 487.96% 166.48% -8.97%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -93.79% -88.33% -- -37.60% -93.43%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 93.97% -- -- -- -8.41%
Cash from Financing 18,548.05% -88.33% -- -37.60% -100.16%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 101.25% -82.88% 103.34% 106.92% -343.64%